Editorial: Sickle cell disease in the 21st century—Morbidity to molecular biology
Main Author: | Dipika Mohanty |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2022.1100846/full |
Similar Items
-
The Alberta Newborn Screening Approach for Sickle Cell Disease: The Advantages of Molecular Testing
by: Janet R. Zhou, et al.
Published: (2021-11-01) -
Newborn Screening for Sickle Cell Disease in Europe
by: Yvonne Daniel, et al.
Published: (2019-02-01) -
Liver Cirrhosis in a Patient with Sickle Cell Trait (Hb Sβ+ Thalassemia) without Other Known Causes of Hepatic Disease
by: Luca Santi, et al.
Published: (2009-09-01) -
Incidence, demographic characteristics, and geographic distribution of sickle cell trait and sickle cell anemia births in Michigan, 1997–2014
by: Sarah L. Reeves, et al.
Published: (2019-08-01) -
Automated Red Cell Exchange in the Management of Sickle Cell Disease
by: Dimitris A. Tsitsikas, et al.
Published: (2021-02-01)